EDIT
Price
$2.60
Change
+$0.04 (+1.56%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
217.65M
97 days until earnings call
GFS
Price
$32.81
Change
-$3.37 (-9.31%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
18.2B
Earnings call today
Interact to see
Advertisement

EDIT vs GFS

Header iconEDIT vs GFS Comparison
Open Charts EDIT vs GFSBanner chart's image
Editas Medicine
Price$2.60
Change+$0.04 (+1.56%)
Volume$18.86K
Capitalization217.65M
GlobalFoundries
Price$32.81
Change-$3.37 (-9.31%)
Volume$135.95K
Capitalization18.2B
EDIT vs GFS Comparison Chart in %
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. GFS commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and GFS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (EDIT: $2.60 vs. GFS: $32.80)
Brand notoriety: EDIT and GFS are both not notable
EDIT represents the Biotechnology, while GFS is part of the Semiconductors industry
Current volume relative to the 65-day Moving Average: EDIT: 63% vs. GFS: 459%
Market capitalization -- EDIT: $217.65M vs. GFS: $18.2B
EDIT [@Biotechnology] is valued at $217.65M. GFS’s [@Semiconductors] market capitalization is $18.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The market cap for tickers in the [@Semiconductors] industry ranges from $4.35T to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B. The average market capitalization across the [@Semiconductors] industry is $63.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileGFS’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • GFS’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than GFS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while GFS’s TA Score has 5 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 5 bearish.
  • GFS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GFS is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +0.39% price change this week, while GFS (@Semiconductors) price change was -18.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.41%. For the same industry, the average monthly price growth was +15.08%, and the average quarterly price growth was +12.00%.

The average weekly price growth across all stocks in the @Semiconductors industry was -3.32%. For the same industry, the average monthly price growth was -0.78%, and the average quarterly price growth was +2.01%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 10, 2025.

GFS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Semiconductors (-3.32% weekly)

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GFS($18.2B) has a higher market cap than EDIT($218M). EDIT YTD gains are higher at: 101.575 vs. GFS (-15.684). GFS has higher annual earnings (EBITDA): 1.47B vs. EDIT (-244.52M). GFS has more cash in the bank: 2.9B vs. EDIT (221M). EDIT has less debt than GFS: EDIT (31.1M) vs GFS (1.63B). GFS has higher revenues than EDIT: GFS (6.79B) vs EDIT (35.8M).
EDITGFSEDIT / GFS
Capitalization218M18.2B1%
EBITDA-244.52M1.47B-17%
Gain YTD101.575-15.684-648%
P/E RatioN/A28.59-
Revenue35.8M6.79B1%
Total Cash221M2.9B8%
Total Debt31.1M1.63B2%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITGFS
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 14 days ago
77%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CSMD32.170.41
+1.29%
Congress SMid Growth ETF
XBJA30.570.25
+0.84%
Innovator US Eq Acclrtd 9 Bffr ETF Jan
HYLS41.800.14
+0.34%
First Trust Tactical High Yield ETF
HCOW23.190.01
+0.02%
Amplify COWS Covered Call ETF
SPBX26.200.01
+0.02%
AllianzIM 6 Month Buffer10 Allocation ETF

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRSP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+4.92%
CRSP - EDIT
52%
Loosely correlated
+5.92%
AXON - EDIT
52%
Loosely correlated
+0.32%
VCYT - EDIT
49%
Loosely correlated
+2.88%
NTLA - EDIT
48%
Loosely correlated
+5.48%
RXRX - EDIT
48%
Loosely correlated
+2.11%
More

GFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GFS has been closely correlated with KLIC. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if GFS jumps, then KLIC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GFS
1D Price
Change %
GFS100%
-1.09%
KLIC - GFS
74%
Closely correlated
+1.67%
LSCC - GFS
72%
Closely correlated
-0.53%
ON - GFS
72%
Closely correlated
-15.58%
FORM - GFS
71%
Closely correlated
+1.28%
POWI - GFS
71%
Closely correlated
+3.65%
More